IL4 and triple-negative breast carcinoma: To assess these metabolic effects on triple-negative breast cancer in vitro, we treated two cell lines capable of spontaneous metastasis, human (MDA-MB-231) and murine (4T1) cell lines, with IL4 and quantified glucose uptake using the fluorescent glucose analog 2-NBDG.